Cargando…
Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study
SARS-CoV-2 infection goes beyond acute pneumonia, as it also impacts lipid metabolism. Decreased HDL-C and LDL-C levels have been reported in patients with COVID-19. The lipid profile is a less robust biochemical marker than apolipoproteins, components of lipoproteins. However, the association of ap...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003429/ https://www.ncbi.nlm.nih.gov/pubmed/36902035 http://dx.doi.org/10.3390/ijms24054605 |
_version_ | 1784904605452206080 |
---|---|
author | Begue, Floran Chemello, Kévin Veeren, Bryan Lortat-Jacob, Brice Tran-Dinh, Alexy Zappella, Nathalie Snauwaert, Aurelie Robert, Tiphaine Rondeau, Philippe Lagrange-Xelot, Marie Montravers, Philippe Couret, David Tanaka, Sébastien Meilhac, Olivier |
author_facet | Begue, Floran Chemello, Kévin Veeren, Bryan Lortat-Jacob, Brice Tran-Dinh, Alexy Zappella, Nathalie Snauwaert, Aurelie Robert, Tiphaine Rondeau, Philippe Lagrange-Xelot, Marie Montravers, Philippe Couret, David Tanaka, Sébastien Meilhac, Olivier |
author_sort | Begue, Floran |
collection | PubMed |
description | SARS-CoV-2 infection goes beyond acute pneumonia, as it also impacts lipid metabolism. Decreased HDL-C and LDL-C levels have been reported in patients with COVID-19. The lipid profile is a less robust biochemical marker than apolipoproteins, components of lipoproteins. However, the association of apolipoprotein levels during COVID-19 is not well described and understood. The objective of our study is to measure plasma levels of 14 apolipoproteins in patients with COVID-19 and to evaluate the relationships between apolipoprotein levels, severity factors and patient outcomes. From November to March 2021, 44 patients were recruited on admission to the intensive care unit because of COVID-19. Fourteen apolipoproteins and LCAT were measured by LC-MS/MS in plasma of 44 COVID-19 patients on admission to the ICU and 44 healthy control subjects. Absolute apolipoprotein concentrations were compared between COVID-19 patients and controls. Plasma apolipoproteins (Apo) A (I, II, IV), C(I, II), D, H, J and M and LCAT were lower in COVID-19 patients, whereas Apo E was higher. COVID-19 severity factors such as PaO2/FiO2 ratio, SO-FA score and CRP were correlated with certain apolipoproteins. Lower Apo B100 and LCAT levels were observed in non-survivors of COVID-19 versus survivors. To conclude, in this study, lipid and apolipoprotein profiles are altered in COVID-19 patients. Low Apo B100 and LCAT levels may be predictive of non-survival in COVID-19 patients. |
format | Online Article Text |
id | pubmed-10003429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100034292023-03-11 Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study Begue, Floran Chemello, Kévin Veeren, Bryan Lortat-Jacob, Brice Tran-Dinh, Alexy Zappella, Nathalie Snauwaert, Aurelie Robert, Tiphaine Rondeau, Philippe Lagrange-Xelot, Marie Montravers, Philippe Couret, David Tanaka, Sébastien Meilhac, Olivier Int J Mol Sci Article SARS-CoV-2 infection goes beyond acute pneumonia, as it also impacts lipid metabolism. Decreased HDL-C and LDL-C levels have been reported in patients with COVID-19. The lipid profile is a less robust biochemical marker than apolipoproteins, components of lipoproteins. However, the association of apolipoprotein levels during COVID-19 is not well described and understood. The objective of our study is to measure plasma levels of 14 apolipoproteins in patients with COVID-19 and to evaluate the relationships between apolipoprotein levels, severity factors and patient outcomes. From November to March 2021, 44 patients were recruited on admission to the intensive care unit because of COVID-19. Fourteen apolipoproteins and LCAT were measured by LC-MS/MS in plasma of 44 COVID-19 patients on admission to the ICU and 44 healthy control subjects. Absolute apolipoprotein concentrations were compared between COVID-19 patients and controls. Plasma apolipoproteins (Apo) A (I, II, IV), C(I, II), D, H, J and M and LCAT were lower in COVID-19 patients, whereas Apo E was higher. COVID-19 severity factors such as PaO2/FiO2 ratio, SO-FA score and CRP were correlated with certain apolipoproteins. Lower Apo B100 and LCAT levels were observed in non-survivors of COVID-19 versus survivors. To conclude, in this study, lipid and apolipoprotein profiles are altered in COVID-19 patients. Low Apo B100 and LCAT levels may be predictive of non-survival in COVID-19 patients. MDPI 2023-02-27 /pmc/articles/PMC10003429/ /pubmed/36902035 http://dx.doi.org/10.3390/ijms24054605 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Begue, Floran Chemello, Kévin Veeren, Bryan Lortat-Jacob, Brice Tran-Dinh, Alexy Zappella, Nathalie Snauwaert, Aurelie Robert, Tiphaine Rondeau, Philippe Lagrange-Xelot, Marie Montravers, Philippe Couret, David Tanaka, Sébastien Meilhac, Olivier Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study |
title | Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study |
title_full | Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study |
title_fullStr | Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study |
title_full_unstemmed | Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study |
title_short | Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study |
title_sort | plasma apolipoprotein concentrations are highly altered in severe intensive care unit covid-19 patients: preliminary results from the lipicor cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003429/ https://www.ncbi.nlm.nih.gov/pubmed/36902035 http://dx.doi.org/10.3390/ijms24054605 |
work_keys_str_mv | AT beguefloran plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT chemellokevin plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT veerenbryan plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT lortatjacobbrice plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT trandinhalexy plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT zappellanathalie plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT snauwaertaurelie plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT roberttiphaine plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT rondeauphilippe plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT lagrangexelotmarie plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT montraversphilippe plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT couretdavid plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT tanakasebastien plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy AT meilhacolivier plasmaapolipoproteinconcentrationsarehighlyalteredinsevereintensivecareunitcovid19patientspreliminaryresultsfromthelipicorcohortstudy |